Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial

AIMS/INTRODUCTION: We compared treatment satisfaction in type 2 diabetes patients taking daily and weekly glucagon‐like peptide‐1 receptor agonists. MATERIALS AND METHODS: The study was a 12‐week, multicenter, open‐label, prospective, randomized, parallel‐group comparison trial. The participants wer...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Diabetes Investig
Asıl Yazarlar: Takase, Takahiro, Nakamura, Akinobu, Yamamoto, Chiho, Nomoto, Hiroshi, Miya, Aika, Dannoura, Midori, Cho, Kyu Yong, Kurihara, Yoshio, Manda, Naoki, Aoki, Shin, Atsumi, Tatsuya, Miyoshi, Hideaki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6497607/
https://ncbi.nlm.nih.gov/pubmed/30076787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12906
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller